(Q28204201)

0 references

A A Aqeel

0 references

W A Sewairi

0 references

C E Boumah

0 references

M Kambouris

0 references

S A Mayouf

0 references

K V Sheth

0 references

W A Eid

0 references

O Dowling

0 references

J Harris

0 references

M J Glucksman

0 references

S Bahabri

0 references

B F Meyer

New form of idiopathic osteolysis: nodulosis, arthropathy and osteolysis (NAO) syndrome

0 references

language of work or name

English

0 references

publication date

July 2001

0 references

0 references

0 references

0 references

261-5

0 references

cites work

1 reference

7 January 2021

Inherited multicentric osteolysis with arthritis: a variant resembling Torg syndrome in a Saudi family

1 reference

7 January 2021

Completion of the primary structure of the human type IV collagenase preproenzyme and assignment of the gene (CLG4) to the q21 region of chromosome 16.

1 reference

7 January 2021

Comprehensive human genetic maps: individual and sex-specific variation in recombination

1 reference

7 January 2021

A collection of tri- and tetranucleotide repeat markers used to generate high quality, high resolution human genome-wide linkage maps

1 reference

7 January 2021

An endopeptidase from rheumatoid synovial tissue culture.

1 reference

7 January 2021

Gelatinase A (MMP-2) and cysteine proteinases are essential for the degradation of collagen in soft connective tissue

1 reference

7 January 2021

Basement membrane zone remodeling during appendageal development in human fetal skin. The absence of type VII collagen is associated with gelatinase-A (MMP2) activity

1 reference

7 January 2021

Role of membrane-type matrix metalloproteinase 1 (MT-1-MMP), MMP-2, and its inhibitor in nephrogenesis.

1 reference

7 January 2021

Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed

1 reference

7 January 2021

The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases

1 reference

7 January 2021

Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A

1 reference

7 January 2021

Reconstructed 19 kDa catalytic domain of gelatinase A is an active proteinase

1 reference

7 January 2021

The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family

1 reference

7 January 2021

Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy

1 reference

7 January 2021

Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases

1 reference

7 January 2021

Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice.

1 reference

7 January 2021

MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover

1 reference

7 January 2021

The Matrix Metalloproteinase-14 (MMP-14) Gene Is Structurally Distinct from Other MMP Genes and Is Co-expressed with the TIMP-2 Gene during Mouse Embryogenesis

1 reference

7 January 2021

Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease

1 reference

7 January 2021

The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase A

1 reference

7 January 2021

Osteocyte and osteoblast apoptosis and excessive bone deposition accompany failure of collagenase cleavage of collagen

1 reference

7 January 2021